Monthly Archives: August 2016

Mallinckrodt Completes Acquisition of Stratatech Corporation, a Regenerative Medicine Company Focused on Proprietary Therapeutics for Substituting Human Skin

CHESTERFIELD, United Kingdom, August 31, 2016 / PRNewswire / – Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced that it has completed the acquisition of Stratatech Corporation, a privately-held regenerative medicine company focused on the development of proprietary and proprietary skin replacement products. Development products include StrataGraft® …

Read More »